Chronic disorder of neurologic function Flashcards
characterized by excessive cortical electrical discharges and spontaneous positive potentials r/t Na+
Seizure disorder
neurons are hyperactive and hypersensitive to their environment
seizure disorder pathogenesis
decreased distance between membrane and threshold potential
neurons hypersensitive
Anticonvulsants target
- Positive ions, Na+ and Ca++ (depolarization of the cell)
2. Enhance GABA- inhibitory (hyper polarize cell- Cl-)
PROGRESSIVE deterioration and CONTINUING decline of memory and cognitive changes
Dementia
two types of dementia
Alzheimers and Vascular
degeneration of CORTICAL neurons in temporal and frontal lobes
dementia
brain atrophy around TEMPORAL
amyloid plaques
neurofibulary tangles
Alzheimers
Characterized by a LOSS of function
Alzheimers disease
mild cognitive impairment
NOT Alzheimers
plaques and tangles
proteinopathies
extracellular space
plaques
intracellular space
tanagles
B- amyloid deposits
Plaques
Tau Protein
Tangles
dense central AB core with inflammatory cells and DYSTROPHIC neurites in periphery
plaques
high potential for aggregation and accumulation
plaques
paired helical filament configuration
tangles
disassociates from microtubule and begins to fold
tangles
AB peptide gets clever into
AB42
B-amaeyloid is a byproduct that exists EXTRACELLULARLY and gets cleared in 3 ways normally
- Uptake by another neuron
- Macrophages
- enzymes
INCREASED in alzheimers
CSF Tou
normally stays in neuron membrane, if it has increased in CSF it has LEAKED out of the neuron and their is an accumulation.
DECREASED in alzheimers
- AB42 normally in CSF, if it is decreased it has accumulated somewhere else (extracellular space)
- FDG PET - glucose metabolism ahs decreased indicating decreased neuronal function (neurodegerative disease)
most common byproduct of alzheimers
AB42
risk factor for alzheimerw
E4 allele of APOE has a higher affinity for B-Amyloid
INCREASES metabolism, INCREASES aggregation and DECREASES clearance of AB peptide
E4 allele of APOE
how do we increase or cognitive reserve
exercise your brain and start with a higher baseline
syndrome with evidence of CLINICAL STROKE or VASCULAR BRAIN INJURY
dementia; vascular cognitive impairment
cognitive impairment r/t cerebrovascular injuries
vascular dementia
communication with WHITE MATTER degrades
vascular dementia
vascular dementia from ______________ more so than ____________.
cumulative tissue damage
large cerebral infarcts
atherosclerosis is often associated
hyaline substance in vessel wall- yellow lipid deposits
acute state of brain dysfunction, abrupt onset
delerium
Leukoaraiosis
confluent white matter lesions
Lacunar Infarcts
small, white mater infarcts
CAA
Cerebral amyloid angiopathy
micro infarcts
leading cause of vascular dimentia
progressive failure of cerebral functions, onset is gradual
dementia
hyperkinetic confusional state
delirium with sympathetic NS overactivity
hypokinetic confusional state
delirium with parasympathetic NS Confusional states
degeneration of dopaminergic neurons in basal ganglia and development of LEWY bodies
Parkinsons
TRAP
tremor
rigidity
akinesia/bradykinesia
postural instability
treated with LEVADOPA
Parkinsons
Levadopa = precursor to dopamine
breakdown the precursor to Dopamine
MAO - Parkinsons treated with MAOI
Autoimmune, inflammatory, progressive demyelination of the CNS
Multiple Sclerosis
demyelination often occurs at optic, oculomotor and spinal tracts
Multiple sclerosis
exacerbated by heat, infection, trauma and stress
Multiple sclerosis
MS: immune cells attacking meylin
Autoreactive T cells
MS: activated to chew up myelin sheath
macrophages
MS: these cells DIE, normally function to deposit myelin to cover axons
oligodendorcytes
macrophage alone attacks myelin sheath
macrophage mediated
macrophage works with helper t and b to create antibodies that destroy myelin
Antibody mediated
attacking NERVE ENDING of ODC that is responsible for melioration causing demylination
Distal Oligodendropathy
Macrophage is attacking Oligodendrocyte in General
Primary ODC damage with peripheral Secondary demyelination
double vision, weakness, poor coordination, sensory deficits, bowel and bladder control may be lost memory impairment
Multiple sclerosis symptoms
progressive, UPPER and LOWER motor neurons
ALS
Pathogenesis of ALS
- Excitotoxicity (Glutamate, Ca++)
- Oxidative Stress
- Mitochondrial Dysfunction
- Neuorinflammation
hyperrelexia in weak atrophied extremity
ALS
neurons die in retrograde and anterograde fashin
ALS
secondary injury from spinal cord injury from
swelling
hemorrhage
ischemia
inflammation
temporary loss of reflexes below the spinal cord injury
Spinal Shock
muscles flacid/skeletal and autonomic reflexes lost
spinal shock
Cervical or upper thoracic injury
neurogenic shock
loss of brainstem and higher control of SNS
neurogenic Shock
hypotension, bradycardia, circulatory collapse
Neurogenic shock
secondary complication due to injury of ANS at or above T6
Autonomic Dysreflexia
visceral stimulus or activation of pain receptors BELOW the injury are common stimuli
Autonomic Dysreflexia
manifests as: hypotension, headace, bradycardia, flushing ABOVE the level of injury and clammy BELOW level of injury
Autonomic Dysreflexia
IN Autonomic Dysreflexia a stimulus generates ______________ which will cause widespread ______________ in splanchinc vasculature and an increase in peripheral resistance, where blood is then shunted to _____________ circulation. _______________ sense increased blood pressure and activate the __________________ to lower the blood pressure. with this activation theirs a loss of ____________ tone and increased peripheral ______________.
sympathetic response
vasoconstriction
general circulation
Baroreceptors
PSNS
sympathetic tone
vasodilation
stablilization of vertebrae
treament for Autonomic Dysreflexia
in neurogenic shock we want to
Maintain oxygenation and blood pressure
neuropathic condition with progressive weakness and diminished or absent MYOTATIC reflexes
Guillian- Barre Syndrome
inflammatory, demyelinating disease of the PERIPHERAL nervous system
Guillian- Barre Syndrome
A lower motor neuron disorder
Guillian- Barre Syndrome
AIDP
Guillian- Barre Syndrome
acute inflammatory demyelinating polyneuropathy
muscle weakness that begins in lower extremities and speeds to proximal spinal neurons
Guillian- Barre Syndrome
Treatment include plasmapheresis and immunoglobulin
Guillian- Barre Syndrome